Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/11249
Title: | Ornithine decarboxylase is upregulated by the androgen receptor in skeletal muscle and regulates myoblast proliferation. | Austin Authors: | Lee, Nicole K L;Skinner, Jarrod P J;Zajac, Jeffrey D ;MacLean, Helen E | Affiliation: | Department of Medicine, Austin Health, The University of Melbourne, Heidelberg, Victoria, Australia | Issue Date: | 19-Apr-2011 | Publication information: | American Journal of Physiology. Endocrinology and Metabolism 2011; 301(1): E172-9 | Abstract: | The aim of this study is to determine if the Odc1 gene, which encodes ornithine decarboxylase (ODC), the rate-limiting enzyme in polyamine biosynthesis, is directly regulated by the androgen receptor (AR) in skeletal muscle myoblasts and if Odc1 regulates myoblast proliferation and differentiation. We previously showed that expression of Odc1 is decreased in muscle from AR knockout male mice. In this study, we show in vivo that Odc1 expression is also decreased >60% in muscle from male muscle-specific AR knockout mice. In normal muscle homeostasis, Odc1 expression is regulated by age and sex, reflecting testosterone levels, as muscle of adult male mice expresses high levels of Odc1 compared with age-matched females and younger males. In vitro, expression of Odc1 is 10- and 1.5-fold higher in proliferating mouse C(2)C(12) and human skeletal muscle myoblasts, respectively, than in differentiated myotubes. Dihydrotestosterone increases Odc1 levels 2.7- and 1.6-fold in skeletal muscle cell myoblasts after 12 and 24 h of treatment, respectively. Inhibition of ODC activity in C(2)C(12) myoblasts by α-difluoromethylornithine decreases myoblast number by 40% and 66% following 48 and 72 h of treatment, respectively. In contrast, overexpression of Odc1 in C(2)C(12) myoblasts results in a 27% increase in cell number vs. control when cells are grown under differentiation conditions for 96 h. This prolonged proliferation is associated with delayed differentiation, with reduced expression of the differentiation markers myogenin and Myf6 in Odc1-overexpressing cells. In conclusion, androgens act via the AR to upregulate Odc1 in skeletal muscle myoblasts, and Odc1 promotes myoblast proliferation and delays differentiation. | Gov't Doc #: | 21505150 | URI: | https://ahro.austin.org.au/austinjspui/handle/1/11249 | DOI: | 10.1152/ajpendo.00094.2011 | Journal: | American journal of physiology. Endocrinology and metabolism | URL: | https://pubmed.ncbi.nlm.nih.gov/21505150 | Type: | Journal Article | Subjects: | Androgens.pharmacology Animals Cell Differentiation.drug effects Cell Proliferation.drug effects Cells, Cultured Embryo, Mammalian Female Gene Expression Regulation, Enzymologic.drug effects Humans Male Mice Mice, Inbred C57BL Mice, Transgenic Muscle, Skeletal.drug effects.metabolism.physiology Myoblasts, Skeletal.drug effects.metabolism.physiology Ornithine Decarboxylase.genetics.metabolism Pregnancy Receptors, Androgen.metabolism.physiology Up-Regulation.drug effects |
Appears in Collections: | Journal articles |
Show full item record
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.